India to United States: Tetracycline Export Trade Route

The India to United States Tetracycline corridor is one of India's established pharmaceutical export routes, with 81 shipments documented worth a combined $1.6M USD. The route is dominated by COHANCE LIFESCIENCES LIMITED, which alone accounts for roughly 86% of all export value, reflecting the consolidated nature of India's tetracycline manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $19.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with tetracycline's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 26.9%, placing it at rank #1 among India's top tetracycline export destinations globally.

On the import side, key buyers of Indian tetracycline in United States include CARDINAL HEALTH, CARDINAL HEALTH BRECKNRIDGE PHARMA LAVERGNE IIWARHOUSE, HN PHARMA INC and 29 others. CARDINAL HEALTH is the single largest importer with 31 shipments valued at $1.2M USD.

India's tetracycline exports to United States are driven primarily by a handful of large-scale manufacturers. COHANCE LIFESCIENCES LIMITED with 34 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — COHANCE LIFESCIENCES LIMITED, STRIDES PHARMA SCIENCE LIMITED, WATSON PHARMA PRIVATE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $19.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as tetracycline hydrochloride capsules usp500mg (100s count)nos and tetracycline hydrochloride capsules usp500mg (100 s), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CARDINAL HEALTH is the largest importer with 31 shipments worth $1.2M USD — representing 77% of all tetracycline imports from India on this route. A total of 32 buyers are active on this corridor.